Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study

Table 1

Demographics and baseline diseasecharacteristics of Recent and Long-term diagnosed SZ group.

	Recent SZ (n=10)	Long-term SZ (n=15)	Analyses
	Mean (SD)	Mean T0 (SD)	F	df	p
Age	25.7 (6.5)	43.3 (10.6)	3.618	23	0.001
Years of education	11.9 (2.1)	12.9 (2.4)	0.130	23	0.316
Time since diagnoses (years)	3.5 (1.3)	17.73 (9.4)	9.636	23	0.002
GAF	43.6 (7.8)	40.1 (11.3)	0.797	23	0.408
PANSS Pos	16.2 (6.8)	20.7 (6.9)	0.035	23	0.117
PANSS Neg	17.5 (7.0)	21.1 (6.9)	0.045	23	0.834
PANSS Gen	36.5 (7.1)	36.7 (11.2)	1.466	23	0.238
PANSS Tot	70.2 (11.4)	78.5 (23.6)	3.985	23	0.058
IS severity	1.9 (2.3)	1.1 (2.1)	1.007	23	0.411
IS intensity	6.8 (8.4)	3.9 (7.1)	1.210	23	0.378
RSQ	21.2 (6.1)	22.4 (3.9)	1.288	23	0.553
Social cognition	80.6 (7.9)	81.9 (12.1)	4.383	23	0.756